BACKGROUND: In 2004, the Mozambican Ministry of Health began a national scale-up of antiretroviral therapy (ART) using a vertical model of HIV clinics colocated within large urban hospitals. In 2006, the ministry expanded access by integrating ART into primary health care clinics. METHODS: We conducted a retrospective cohort study including adult ART-naive patients initiating ART between January 2006 and June 2008 in public sector clinics in Manica and Sofala provinces. Cox proportional hazards models with robust variances were used to estimate the association between clinic model (vertical/integrated), clinic location (urban/rural), and clinic experience (first 6 months/post first 6 months) and attrition occurring in early patient follow-up (≤ 6 months) and attrition occurring in late patient follow-up (>6 months), while controlling for age, sex, education, pre-ART CD4 count, World Health Organization stage and pharmacy staff burden. RESULTS: A total of 11,775 patients from 17 clinics were studied. The overall attrition rate was 37 per 100 person-years. Patients attending integrated clinics had a higher risk of attrition in late follow-up [hazard ratio (HR) = 1.75; 95% confidence interval (CI): 1.04 to 2.94], and patients attending urban clinics (HR = 0.57; 95% CI: 0.35 to 0.91) had a lower risk of attrition in late follow-up. Though not statistically significant, clinics open for longer than 6 months (HR = 0.71; 95% CI: 0.49 to 1.04) had a lower risk of attrition in early follow-up. CONCLUSIONS: Patients attending vertical clinics had a lower risk of attrition. Utilizing primary health clinics to implement ART is necessary to reach higher levels of coverage; however, further implementation strategies should be developed to improve patient retention in these settings.
BACKGROUND: In 2004, the Mozambican Ministry of Health began a national scale-up of antiretroviral therapy (ART) using a vertical model of HIV clinics colocated within large urban hospitals. In 2006, the ministry expanded access by integrating ART into primary health care clinics. METHODS: We conducted a retrospective cohort study including adult ART-naive patients initiating ART between January 2006 and June 2008 in public sector clinics in Manica and Sofala provinces. Cox proportional hazards models with robust variances were used to estimate the association between clinic model (vertical/integrated), clinic location (urban/rural), and clinic experience (first 6 months/post first 6 months) and attrition occurring in early patient follow-up (≤ 6 months) and attrition occurring in late patient follow-up (>6 months), while controlling for age, sex, education, pre-ARTCD4 count, World Health Organization stage and pharmacy staff burden. RESULTS: A total of 11,775 patients from 17 clinics were studied. The overall attrition rate was 37 per 100 person-years. Patients attending integrated clinics had a higher risk of attrition in late follow-up [hazard ratio (HR) = 1.75; 95% confidence interval (CI): 1.04 to 2.94], and patients attending urban clinics (HR = 0.57; 95% CI: 0.35 to 0.91) had a lower risk of attrition in late follow-up. Though not statistically significant, clinics open for longer than 6 months (HR = 0.71; 95% CI: 0.49 to 1.04) had a lower risk of attrition in early follow-up. CONCLUSIONS:Patients attending vertical clinics had a lower risk of attrition. Utilizing primary health clinics to implement ART is necessary to reach higher levels of coverage; however, further implementation strategies should be developed to improve patient retention in these settings.
Authors: Joseph Kwong-Leung Yu; Solomon Chih-Cheng Chen; Kuo-Yang Wang; Chao-Sung Chang; Simon D Makombe; Erik J Schouten; Anthony D Harries Journal: Bull World Health Organ Date: 2007-07 Impact factor: 9.408
Authors: Kenneth H Sherr; Mark A Micek; Sarah O Gimbel; Stephen S Gloyd; James P Hughes; Grace C John-Stewart; Rosa M Manjate; James Pfeiffer; Noel S Weiss Journal: AIDS Date: 2010-01 Impact factor: 4.177
Authors: James Pfeiffer; Pablo Montoya; Alberto J Baptista; Marina Karagianis; Marilia de Morais Pugas; Mark Micek; Wendy Johnson; Kenneth Sherr; Sarah Gimbel; Shelagh Baird; Barrot Lambdin; Stephen Gloyd Journal: J Int AIDS Soc Date: 2010-01-20 Impact factor: 5.396
Authors: Mark A Micek; Kenneth Gimbel-Sherr; Alberto João Baptista; Eduardo Matediana; Pablo Montoya; James Pfeiffer; Armando Melo; Sarah Gimbel-Sherr; Wendy Johnson; Stephen Gloyd Journal: J Acquir Immune Defic Syndr Date: 2009-11-01 Impact factor: 3.731
Authors: Rony Zachariah; Anthony David Harries; Marcel Manzi; Patrick Gomani; Roger Teck; Mit Phillips; Peter Firmenich Journal: PLoS One Date: 2006-12-27 Impact factor: 3.240
Authors: Janet M Turan; Maricianah Onono; Rachel L Steinfeld; Starley B Shade; Kevin Owuor; Sierra Washington; Elizabeth A Bukusi; Marta L Ackers; Jackson Kioko; Evelyn C Interis; Craig R Cohen Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Sierra Washington; Kevin Owuor; Janet M Turan; Rachel L Steinfeld; Maricianah Onono; Starley B Shade; Elizabeth A Bukusi; Marta L Ackers; Craig R Cohen Journal: J Acquir Immune Defic Syndr Date: 2015-08-15 Impact factor: 3.731
Authors: Barrot H Lambdin; Ben Cheng; Trevor Peter; Jessie Mbwambo; Tsitsi Apollo; Megan Dunbar; Ifeoma C Udoh; Adithya Cattamanchi; Elvin H Geng; Paul Volberding Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Lucas Molfino; Ajay M V Kumar; Petros Isaakidis; Rafael Van den Bergh; Mohamed Khogali; Sven G Hinderaker; Alice Magaia; Sheila Lobo; Celeste Gracia Edwards; Jan Walter Journal: Glob Health Action Date: 2014-04-08 Impact factor: 2.640
Authors: Sten H Vermund; Meridith Blevins; Troy D Moon; Eurico José; Linda Moiane; José A Tique; Mohsin Sidat; Philip J Ciampa; Bryan E Shepherd; Lara M E Vaz Journal: PLoS One Date: 2014-10-20 Impact factor: 3.240